• Passage Bio eyes gene therapy progress as Nasdaq-listed biotech develops CNS pipeline AD HOC NEWS Wed, 08 Jul 2026 12:34:07 GMT
• Passage Bio focuses on genetic medicine strategy as investors weigh long-term potential AD HOC NEWS Tue, 07 Jul 2026 17:44:53 GMT
• Lynx1 Capital Management LP Increases Stake in Passage Bio Inc GuruFocus Sat, 04 Jul 2026 00:59:50 GMT
• Passage Bio explores gene therapy potential as investors weigh long-term prospects AD HOC NEWS Fri, 03 Jul 2026 15:57:20 GMT
• Lynx1 Capital Management Discloses Investment at Passage BIO with 21.0% Stake TradingView Fri, 03 Jul 2026 01:26:00 GMT
• Passage BIO (NASDAQ: PASG) holder Lynx1 reports 21% ownership amid Remix deal Stock Titan Fri, 03 Jul 2026 01:23:19 GMT
• Passage Bio (PASG) Slides 6% as Shares Test Key Support Near $4.35 - AD Line Divergence dars.gov.et Wed, 01 Jul 2026 23:40:30 GMT
• latham & watkins advises remix therapeutics in merger with passage bio Legal Desire Media and Insights Tue, 30 Jun 2026 09:31:51 GMT
• passage bio to merge with remix in deal backed by $100 million financing MyChesCo Mon, 29 Jun 2026 16:41:56 GMT
• Passage Bio (PASG) holder adds 50,055 shares in open-market buy Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• PASG Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock Up 8.55% - Earnings Revision Report dars.gov.et Mon, 29 Jun 2026 07:00:00 GMT
• enterprise value to ebit forward of passage bio, inc. – nasdaq:pasg TradingView Fri, 26 Jun 2026 09:18:09 GMT
• layoff tracker: biogen axes ‘small number’ of apellis roles after $5.6b buy BioSpace Fri, 26 Jun 2026 07:00:00 GMT
• Latham & Watkins Advises Remix Therapeutics in Merger With Passage Bio Latham & Watkins LLP Fri, 26 Jun 2026 06:57:28 GMT
• price to sales forward of passage bio, inc. – nasdaq:pasg TradingView Fri, 26 Jun 2026 05:37:49 GMT
• price to book forward of passage bio, inc. – nasdaq:pasg TradingView Fri, 26 Jun 2026 04:49:03 GMT
• Enterprise value to EBITDA forward of Passage Bio, Inc. – NASDAQ:PASG TradingView Fri, 26 Jun 2026 04:47:25 GMT
• After setbacks, ailing Philadelphia biotech company finds merger partner The Business Journals Thu, 25 Jun 2026 15:16:00 GMT
• 12 health care stocks moving in thursday's pre-market session Benzinga Thu, 25 Jun 2026 12:05:34 GMT
• remix to enter nasdaq through passage bio reverse merger The Pharma Letter Thu, 25 Jun 2026 10:01:41 GMT
• Remix to go public in reverse merger with once high-flying Passage Bio BioPharma Dive Thu, 25 Jun 2026 07:00:00 GMT
• Baselake Partners (PASG) reports 235,058 shares, 7.3% ownership Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Remix Therapeutics secures $100M and a reverse merger The Business Journals Thu, 25 Jun 2026 07:00:00 GMT
• passage bio and remix therapeutics announce merger to advance rna-targeted cancer therapies with $100m financing – minichart Minichart Thu, 25 Jun 2026 04:05:00 GMT
• SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today TradingView Thu, 25 Jun 2026 01:43:00 GMT
• biopharma bites: remix's reverse merger, absci's raise, adc's layoffs, and a new r&d head for lundbeck FirstWord Pharma Wed, 24 Jun 2026 23:14:36 GMT
• spurned by fda, passage bio finds exit through merger with remix Fierce Biotech Wed, 24 Jun 2026 21:20:00 GMT
• passage bio merges with remix therapeutics in all-stock deal TipRanks Wed, 24 Jun 2026 20:59:20 GMT
• passage bio | 425: filing under securities act rule 425 of certain prospectuses and communications in connection with business com... Moomoo Wed, 24 Jun 2026 20:17:25 GMT
• Remix to take Nasdaq spot of Passage Bio in reverse merger for mRNA degrader Endpoints News Wed, 24 Jun 2026 20:10:35 GMT
• Passage Bio and Remix Therapeutics Announce Merger Agreement GlobeNewswire Wed, 24 Jun 2026 20:05:00 GMT
• PASG Stock Slumps 16% After-Hours - What's Driving The Selloff? Mena FN Wed, 24 Jun 2026 11:30:26 GMT
• Spurned by the FDA, Passage Bio finds an exit through Remix Fierce Biotech Wed, 24 Jun 2026 07:00:00 GMT
• Passage Bio (PASG) to combine with Remix; Remix valued at $226M, $100M raise Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Press Release: Passage Bio and Remix Therapeutics Announce Merger Agreement Moomoo Wed, 24 Jun 2026 07:00:00 GMT
• Passage Bio to merge with Remix Therapeutics in all-stock deal Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• Passage Bio (PASG) to merge with Remix; Remix private placement tops $100M Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Passage Bio to Merge With Remix Therapeutics; Remix Valued at $226M, $100M Financing TradingView Wed, 24 Jun 2026 07:00:00 GMT
• Remix Therapeutics to reverse-merge with Passage Bio (PASG) and raise $100M Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff? TradingView Wed, 24 Jun 2026 07:00:00 GMT
• Stocks to Watch: Micron, ARS Pharmaceuticals, MillerKnoll, Passage Bio Moomoo Wed, 24 Jun 2026 07:00:00 GMT
• 9 health care stocks moving in wednesday's after-market session Sahm Wed, 24 Jun 2026 07:00:00 GMT
• layoff tracker: adc therapeutics lays off 17% of global workforce BioSpace Wed, 24 Jun 2026 07:00:00 GMT
• Remix Therapeutics, Inc. entered into a definitive merger agreement to acquire Passage Bio, Inc. in a reverse merger transaction f... marketscreener.com Tue, 23 Jun 2026 07:00:00 GMT
• passage bio inc (pasg) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• passage bio inc (pasg) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 05:34:03 GMT
• passage bio inc (pasg) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 20:34:56 GMT
• passage bio inc (pasg) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 20:34:40 GMT
• passage bio inc (pasg) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 20:34:07 GMT
• Passage Bio Inc (PASG) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Wed, 17 Jun 2026 19:59:02 GMT
• passage bio inc (pasg) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 14:26:28 GMT
• passage bio inc (pasg) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 14:22:19 GMT
• layoff tracker: neumora, engene cut staff in cost-saving initiatives BioSpace Tue, 16 Jun 2026 07:00:00 GMT
• passage bio inc (pasg) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• layoff tracker: genentech r&d cuts include longtime top exec BioSpace Fri, 12 Jun 2026 07:00:00 GMT
• passage bio inc. (pasg) surges over 9% as biotech stock tests key resistance - earnings quality factor newsline.com Thu, 11 Jun 2026 23:46:06 GMT
• passage bio (pasg) downgraded to neutral as strategic review ini GuruFocus Wed, 10 Jun 2026 13:29:40 GMT
• layoff tracker: fulcrum axes 85% of staff after walking away from lead asset BioSpace Mon, 08 Jun 2026 07:00:00 GMT
• Passage Bio (PASG) Slides 6.33% as Stock Approaches Key Support at $5.34 - Overbought Signal Alerts dars.gov.et Sat, 06 Jun 2026 07:00:00 GMT
• passage bio inc. (pasg) q1 2026 earnings: narrower-than-expected loss drives positive sentiment - gaap earnings report newsline.com Tue, 02 Jun 2026 07:00:00 GMT
• pasg q1 2026 earnings: narrower-than-expected loss lifts sentiment - analyst consensus shift newsline.com Sat, 30 May 2026 07:00:00 GMT
• passage bio inc. (pasg) edges higher as buyers defend key support level - cumulative volume thelegaladvocate.com Fri, 29 May 2026 23:36:34 GMT
• passage bio inc. (pasg) shows modest gains amid consolidation near key levels - high low breadth newsline.com Fri, 29 May 2026 07:00:00 GMT
• passage bio - terminates research, collaboration and license agreement with gemma bio therapeutics TradingView Wed, 27 May 2026 20:30:21 GMT
• Passage Bio (PASG) Holds Steady Near Support as Gene Therapy Sector Faces Crosscurrents - Gap Up Stocks dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• passage bio inc. (pasg) q1 2026 earnings: narrower-than-expected loss fuels share gains - one-time gain impact newsline.com Wed, 27 May 2026 07:00:00 GMT
• passage bio (nasdaq: pasg) ends gemma deal, pays $2.3m to exit lease Stock Titan Wed, 27 May 2026 07:00:00 GMT
• passage bio ends gemma collaboration, philadelphia office lease Moomoo Wed, 27 May 2026 07:00:00 GMT
• passage bio, inc. 2026 annual meeting results: stockholder votes and key corporate information (form 8-k) Minichart Tue, 26 May 2026 12:49:00 GMT
• passage bio (nasdaq: pasg) holders choose annual say-on-pay at 2026 meeting Stock Titan Tue, 26 May 2026 07:00:00 GMT
• passage bio shareholders approve directors and executive pay TipRanks Tue, 26 May 2026 07:00:00 GMT
• pasg q1 2026 earnings: smaller-than-expected loss drives positive market response - core business growth newsline.com Tue, 26 May 2026 07:00:00 GMT
• pasg stock price, quote & chart | passage bio inc (nasdaq:pasg) ChartMill Tue, 26 May 2026 07:00:00 GMT
• Passage Bio Q1 2026 Earnings: Narrower-than-expected loss signals disciplined spending - GAAP Earnings Report dars.gov.et Sun, 24 May 2026 07:00:00 GMT
• passage bio q1 2026 earnings: narrower-than-expected loss drives positive sentiment - ceo earnings statement The Legal Advocate Sat, 23 May 2026 13:38:12 GMT
• pasg q1 2026 earnings: narrower-than-expected loss lifts shares - saas earnings trends newsline.com Sat, 23 May 2026 07:00:00 GMT
• Director Sondhi Dolan receives 10,539 Passage BIO (PASG) stock options Stock Titan Thu, 21 May 2026 07:00:00 GMT
• passage bio | 4: statement of changes in beneficial ownership of securities-director kapadia sandip Moomoo Thu, 21 May 2026 07:00:00 GMT
• passage bio, inc. (pasg) director gets 10,539 stock options at $5.08 Stock Titan Thu, 21 May 2026 07:00:00 GMT
• passage bio (pasg) director receives 10,539 stock options at $5.08 Stock Titan Thu, 21 May 2026 07:00:00 GMT
• passage bio inc stock (us70267e1055): gene therapy developer back in focus after recent moves AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• passage bio (pasg) director sandip kapadia awarded 10,539 stock options at $5.08 Stock Titan Thu, 21 May 2026 07:00:00 GMT
• passage bio (pasg) awards 10,539 options to director at $5.08 Stock Titan Thu, 21 May 2026 07:00:00 GMT
• passage bio (nasdaq: pasg) director derrell porter receives grant of 10,539 stock options Stock Titan Thu, 21 May 2026 07:00:00 GMT
• passage bio inc. (pasg) holds steady near support as biotechnology sector faces headwinds - sector neutral pair The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside? Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• passage bio inc stock (us70267e1055): gene therapy hopes meet analyst caution AD HOC NEWS Tue, 19 May 2026 10:15:31 GMT
• Passage Bio Announces Discontinuation of upliFT-D Clinical Trial for FTD-GRN AFTD - The Association for Frontotemporal Degeneration Fri, 15 May 2026 07:00:00 GMT
• Passage Bio to cut its workforce to the bone, laying off 75% of remaining employees The Business Journals Fri, 15 May 2026 07:00:00 GMT
• layoff tracker: takeda cuts 4,500, novartis lays off biomedical research staff BioSpace Fri, 15 May 2026 07:00:00 GMT
• passage bio stock (us70267e1055): cuts 75% of workforce after fda feedback AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• krabbe disease treatment market to reach usd 786.45 million openPR.com Wed, 13 May 2026 05:45:25 GMT
• passage bio, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 11:02:00 GMT
• ccorf maintains passage bio(pasg.us) with buy rating, maintains target price $23 Moomoo Tue, 12 May 2026 07:08:50 GMT
• gm1 gangliosidosis treatment market to reach usd 626.86 million openPR.com Tue, 12 May 2026 07:00:00 GMT
• passage bio, inc. 1q 2026: net loss $(7.6)m, eps $(2.36) — 10-q summary TradingView Tue, 12 May 2026 07:00:00 GMT
• passage bio (nasdaq: pasg) faces cash shortfall, cuts workforce 75% Stock Titan Tue, 12 May 2026 07:00:00 GMT
• why passage bio (pasg) business model holds up in any market (smart money active) 2026-05-11 - keltner channel newsline.com Mon, 11 May 2026 07:00:00 GMT
• a quick look at today's ratings for passage bio(pasg.us), with a forecast between $21 to $32 Moomoo Mon, 11 May 2026 06:36:31 GMT
• number of shareholders of passage bio, inc. – boats:pasg TradingView Sun, 10 May 2026 21:15:50 GMT
• a quick look at today's ratings for passage bio(pasg.us), with a forecast between $8 to $23 Moomoo Sun, 10 May 2026 02:38:25 GMT
• passage bio inc expected to post a loss of $2.79 a share - earnings preview TradingView Fri, 08 May 2026 16:31:07 GMT
• gene therapy briefs: regeneron wins fda approval for first neurosensory gene therapy Genetic Engineering and Biotechnology News Fri, 08 May 2026 07:00:00 GMT
• layoff tracker: gilead laying off vast majority of arcellx employees BioSpace Fri, 08 May 2026 07:00:00 GMT
• ccorf maintains passage bio(pasg.us) with buy rating, maintains target price $23 富途牛牛 Tue, 05 May 2026 23:39:00 GMT
• Passage launches strategic review and 75% layoffs after gene therapy path blocked by FDA Fierce Biotech Mon, 04 May 2026 07:00:00 GMT
• Passage cuts 75% of workforce after FDA trial design request BioSpace Mon, 04 May 2026 07:00:00 GMT
• layoff tracker: passage axes 75% of staff, explores strategic alternatives BioSpace Thu, 30 Apr 2026 07:00:00 GMT
• passage bio (nasdaq: pasg) slashes workforce by 75% in 2026 restructuring Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• passage bio announces major workforce reduction and restructuring TipRanks Tue, 28 Apr 2026 07:00:00 GMT
• Passage Bio Shares Latest Interim Data from UpliFT-D Clinical Trial AFTD - The Association for Frontotemporal Degeneration Fri, 24 Apr 2026 07:00:00 GMT
• pasg (passage bio) reports wider-than-expected q4 2025 loss, shares dip 1.02% amid negative investor sentiment. - high growth earn... newsline.com Fri, 24 Apr 2026 07:00:00 GMT
• canaccord genuity remains a buy on passage bio (pasg) The Globe and Mail Wed, 22 Apr 2026 07:00:00 GMT
• a quick look at today's ratings for passage bio(pasg.us), with a forecast between $8 to $23 富途牛牛 Wed, 22 Apr 2026 07:00:00 GMT
• wedbush downgrades passage bio(pasg.us) to hold rating, cuts target price to $8 富途牛牛 Wed, 22 Apr 2026 03:45:25 GMT
• pasg downgraded by chardan capital -- price target lowered to $7 GuruFocus Tue, 21 Apr 2026 20:15:00 GMT
Passage Bio, Inc(NASDAQ:PASG) 
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid b...
Website: http://www.passagebio.com
Founded: 2017
Full Time Employees: 20
CEO: Bruce A. Goldsmith
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends